La terapia inalatoria: una monografia di Pneumologia ... - SIAIP

56
Battistini
24. Bisgaard H, Klug B, Sunby BS, Burnell PKB. Fine
particle mass from the Diskus inhaler and Turbohaler
inhaler in children with astma. Eur Respir J 1998;
11: 1111-1115.
25. O’Byrne PM. Delivery and the importance of
the inhalation device in asthma therapy. Eur Respir
Rev 1997; 7: 362-365.
26. Agertoft L, Pedersen S. Importance of training
for correct Turbuhaler use in preschool children. Acta
Paediatr 1998; 87: 842-848.
27. De Boeck K, Alifier M,Warnier G. Is the correct
use of a dry powder inhaler (Turbuhaler) age dependent?
J Allergy Clin Immunol 1999; 103: 763-767.
28. Agertoft L, Pedersen S. Importance of the inhalation
device on the effect of budesonide. Arch Dis
Child 1993; 69: 130-133.
29. Nana A,Youngchaiyud P, Maranetra N, et al. bagonists
administered by a dry powder inhaler can
be used in acute asthma. Respir Med 1998; 92:
167-172.
30. Lipworth BJ, Clark DJ. Lung delivery of salbutamol
by dry powder inhaler (Turbuhaler ® ) and small
volume antistatic metal spacer (Airomir ® CFC-free
MDI plus NebuChamber ® ). Eur Respir J 1997; 10:
1820-1823.
31. Volovitz B, Bentur L, Finkelstein Y, et al.
Effectiveness and safety of inhaled corticosteroids in
controlling acute asthma attacks in children who
were treated in the emergency department: A controlled
comparative study with oral prednisolone. J
Allergy Clin Immunol 1998; 102: 605-609.
32. Shapiro G, Bronsky EA, LaForce CF, et al.
Dose-related efficacy of budesonide administered
via a dry powder inhaler in the treatment of children
with moderate to severe persistent asthma. J Pediatr
1998; 132: 976-982.
33. Peden DB, Berger WE, Noonan MJ, et al.
Inhaled fluticasone propionate delivered by means
of two different multidose powder inhalers is effecti-
ve and safe in a large pediatric population with per-
sistent asthma.J Allergy Clin Immunol 1998; 102:
32-38.
34. Nelson HS, Busse WW, deBoisblanc BP, et al.
Fluticasone propionate powder: oral corticosteroid -
sparing effect and improved lung function and quality
of life in patients with severe chronic asthma. J
Allergy Clin Immunol 1999; 103: 267-275.
35. Pedersen S, O’Byrne P. A comparision of the
efficacy and safety of inhaled corticosteroids in asthma.
Allergy 1997; 52 (Suppl 39): 1-34.
36. Bisgaard H. Drug delivery from inhaler devices.
BMJ 1996; 313: 895-896.
37. Gillies J. Overview of delivery system issues in
pediatric asthma. Pediatr Pulmonol 1997;
Supplement 15: 55-58.
38. Van Beerendonk I, Mesters I, Mudde AN,Tan
TD. Assessment of the inhalation technique in outpatients
with asthma or chronic obstructive pulmonary
disease using a metered-dose inhaler or dry
powder device. J Asthma 1998; 35 (3): 273-279.
39. Kamps AWA, Brand PLP, Roorda RJ.
Determinants of correct inhalation technique in children
attending a hospital- based asthma clinic. Acta
Paediatr 2002; 91: 152-163.
40. Dolovich MB, Fink JB. Aerosols and devices.
Respir Care Clin N A 2001; 7: 131-173.
BIBLIOGRAFIA